Back to Search Start Over

Time from diagnosis to institutionalization and death in people with dementia

Authors :
Birgit I. Lissenberg-Witte
Olin Janssen
Karlijn J. Joling
Hein P.J. van Hout
Pieter Jelle Visser
Robert A Verheij
Anneke L. Francke
Psychiatrie & Neuropsychologie
RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience
General practice
APH - Aging & Later Life
APH - Quality of Care
Public and occupational health
Epidemiology and Data Science
Neurology
Amsterdam Neuroscience - Neurodegeneration
APH - Methodology
APH - Digital Health
APH - Mental Health
Source :
Joling, K J, Janssen, O, Francke, A L, Verheij, R A, Lissenberg-Witte, B I, Visser, P-J & van Hout, H P J 2020, ' Time from diagnosis to institutionalization and death in people with dementia ', Alzheimer's & dementia : the journal of the Alzheimer's Association, vol. 16, no. 4, pp. 662-671 . https://doi.org/10.1002/alz.12063, Alzheimer's & Dementia, 16(4), 662-671. Elsevier Science, Alzheimer's & dementia : the journal of the Alzheimer's Association, 16(4), 662-671. Elsevier, Alzheimer's & Dementia
Publication Year :
2020

Abstract

INTRODUCTION: Reliable estimates of time from diagnosis until institutionalization and death in people with dementia from routine nationally representative databases are lacking.METHODS: We selected 9230 people with dementia and 24,624 matched controls from family physicians' electronic records linked with national administrative databases to analyze time until institutionalization and death and associated factors.RESULTS: Median time from recorded diagnosis until institutionalization and until death for people with dementia was 3.9 and 5.0 years, respectively, which was considerably shorter than for controls. Once institutionalized, median time to death was longer for persons with dementia (2.5 years) than for controls (1.2 years). Older age and receiving home care were the strongest predictors of shorter time until institutionalization and death in people with dementia. Gender, cohabitation, migration status, frailty, polypharmacy, and dementia medication were other significant factors.DISCUSSION: The estimates could help to inform patients, their families, and policymakers about probable trajectories.

Details

Language :
English
ISSN :
15525260
Volume :
16
Issue :
4
Database :
OpenAIRE
Journal :
Alzheimer's & Dementia
Accession number :
edsair.doi.dedup.....15e7bc0f549328611f99c3ce1ed4c037
Full Text :
https://doi.org/10.1002/alz.12063